Dyskinesia, Drug-Induced (epidemiology) < Dyskinesia, Drug-Induced (etiology) < Dyskinesia, Drug-Induced (genetics)

Facettes :

List of bibliographic references indexed by Dyskinesia, Drug-Induced (etiology)

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]

Ident.	Authors (with country if any)	Title
000398 (2016)	Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau	D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000794 (2015)	Camila Catherine Aquino [Canada] ; Susan H. Fox	Clinical spectrum of levodopa-induced complications.
000801 (2015)	Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di Paolo	Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
000933 (2014)	Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]	Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
000A17 (2014)	I A Prescott [Canada] ; L D Liu [Canada] ; J O Dostrovsky [Canada] ; M. Hodaie [Canada] ; A M Lozano [Canada] ; W D Hutchison [Canada]	Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
000A70 (2014)	Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. Fox	Emerging drugs for levodopa-induced dyskinesia.
000B60 (2014)	Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada]	AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.
000C43 (2013)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
000C50 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001508 (2012)	Behzad Elahi [Canada] ; Nicolás Phielipp [Canada] ; Robert Chen [Canada]	N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta- Analysis
001590 (2011)	Tejas Sankar [Canada] ; Andres M. Lozano	Surgical approach to l-dopa-induced dyskinesias.
002081 (2009)	Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada]	Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients
002158 (2008)	Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie	Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
002380 (2008)	Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada]	Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea
002455 (2007)	Jackie Gour [Canada] ; Roderick Edwards ; Sarah Lemieux ; Mehrdad Ghassemi ; Mandar Jog ; Christian Duval	Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
002630 (2007)	Sarah Lemieux [Canada] ; Mehrdad Ghassemi [Canada] ; Mandar Jog [Canada] ; Roderick Edwards [Canada] ; Christian Duval [Canada]	The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease
002725 (2006)	Pershia Samadi [Canada] ; Paul J. Bédard ; Claude Rouillard	Opioids and motor complications in Parkinson's disease.
002751 (2006)	Mehrdad Ghassemi [Canada] ; Sarah Lemieux ; Mandar Jog ; Roderick Edwards ; Christian Duval	Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
002822 (2006)	Francesca Morgante [Canada] ; Alberto J. Espay [Canada] ; Carolyn Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]	Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias
002883 (2006)	Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon Stoessl	Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
002B55 (2004)	Harold D. Foster [Canada] ; Abram Hoffer	The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dyskinesia, Drug-Induced (etiology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dyskinesia, Drug-Induced (etiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia, Drug-Induced (etiology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022